Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inspired Futures AI is a London-based biotechnology company that leverages artificial intelligence to accelerate drug discovery and development. Founded by experts in AI and network pharmacology, the company focuses on identifying novel therapeutic targets and repurposing existing drugs for complex diseases with high unmet needs. Its proprietary AI platform integrates vast biological, clinical, and chemical datasets to predict drug-target interactions and optimize lead candidates. The company's primary therapeutic areas of interest include oncology, neurodegeneration, and rare diseases. By streamlining the early stages of the R&D process, Inspired Futures AI aims to deliver more effective treatments to patients faster and more cost-effectively. The firm operates through a combination of internal pipeline development and strategic collaborations with global pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inspired Futures AI.